AU2013219148B2 - Uses of DPP-IV inhibitors - Google Patents
Uses of DPP-IV inhibitorsInfo
- Publication number
- AU2013219148B2 AU2013219148B2 AU2013219148A AU2013219148A AU2013219148B2 AU 2013219148 B2 AU2013219148 B2 AU 2013219148B2 AU 2013219148 A AU2013219148 A AU 2013219148A AU 2013219148 A AU2013219148 A AU 2013219148A AU 2013219148 B2 AU2013219148 B2 AU 2013219148B2
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- dpp
- disclosed
- disorders
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 title abstract 3
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Disclosed is the use of selected DPP-IV inhibitors for treating physiological functional disorders and reducing the risk of at-risk patient groups developing such functional 5 disorders. Also disclosed is the use of said DPP-IV inhibitors in combination with other agents such that improved treatment results can be obtained. Said uses can be employed for producing corresponding medicaments.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013219148A AU2013219148B2 (en) | 2006-05-04 | 2013-08-19 | Uses of DPP-IV inhibitors |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06009203.8 | 2006-05-04 | ||
AU2007247141A AU2007247141B2 (en) | 2006-05-04 | 2007-05-03 | Uses of DPP-IV inhibitors |
AU2013219148A AU2013219148B2 (en) | 2006-05-04 | 2013-08-19 | Uses of DPP-IV inhibitors |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2007247141A Division AU2007247141B2 (en) | 2006-05-04 | 2007-05-03 | Uses of DPP-IV inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2013219148A1 AU2013219148A1 (en) | 2013-09-05 |
AU2013219148B2 true AU2013219148B2 (en) | 2016-07-14 |
Family
ID=48444738
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013203306A Active AU2013203306B2 (en) | 2006-05-04 | 2013-04-10 | Uses of DPP-IV inhibitors |
AU2013219148A Active AU2013219148B2 (en) | 2006-05-04 | 2013-08-19 | Uses of DPP-IV inhibitors |
AU2013219147A Active AU2013219147B2 (en) | 2006-05-04 | 2013-08-19 | Uses of DPP-IV inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013203306A Active AU2013203306B2 (en) | 2006-05-04 | 2013-04-10 | Uses of DPP-IV inhibitors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013219147A Active AU2013219147B2 (en) | 2006-05-04 | 2013-08-19 | Uses of DPP-IV inhibitors |
Country Status (1)
Country | Link |
---|---|
AU (3) | AU2013203306B2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004044221A1 (en) * | 2004-09-14 | 2006-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New 3-methyl-7-butynyl xanthines, their preparation and their use as pharmaceuticals |
-
2013
- 2013-04-10 AU AU2013203306A patent/AU2013203306B2/en active Active
- 2013-08-19 AU AU2013219148A patent/AU2013219148B2/en active Active
- 2013-08-19 AU AU2013219147A patent/AU2013219147B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2013203306A1 (en) | 2013-05-02 |
AU2013203306B2 (en) | 2016-07-21 |
AU2013219147B2 (en) | 2016-07-14 |
AU2013219147A1 (en) | 2013-09-05 |
AU2013219148A1 (en) | 2013-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA102669C2 (en) | Use of dpp-iv inhibitors | |
IL267381A (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
MX2010004074A (en) | Combination 059. | |
HUS1600049I1 (en) | Inhibitors of bruton's tyrosine kinase | |
EP2286840A3 (en) | Treatment of obesity and related diseases | |
MXPA05008406A (en) | Phenylacetamides and their use as glucokinase modulators. | |
WO2008133928A3 (en) | Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders | |
SG146451A1 (en) | Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient | |
MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
WO2005037323A3 (en) | Use of gro to treat or prevent inflammation | |
GB0416508D0 (en) | Therapeutic agents | |
MXPA05001885A (en) | The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis. | |
AU2013219147B2 (en) | Uses of DPP-IV inhibitors | |
TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
AU2003229876A1 (en) | Tumour associated antigens | |
GB2445882A (en) | Prophylactic and therapeutic agents and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |